Cargando…

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis

Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurchla, Michelle A., Weilbaecher, Katherine N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518520/
https://www.ncbi.nlm.nih.gov/pubmed/23243611
http://dx.doi.org/10.4161/onci.21060
_version_ 1782252568102043648
author Hurchla, Michelle A.
Weilbaecher, Katherine N.
author_facet Hurchla, Michelle A.
Weilbaecher, Katherine N.
author_sort Hurchla, Michelle A.
collection PubMed
description Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to bone metastasis that involves osteoblasts, osteoclasts, and tumor cells.
format Online
Article
Text
id pubmed-3518520
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-35185202012-12-14 Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis Hurchla, Michelle A. Weilbaecher, Katherine N. Oncoimmunology Author's View Paracrine Hedgehog (Hh) signaling, in which tumor-derived Hh ligands activate stromal cells, has been implicated in the development and progression of many cancers. Recent data suggest that Hh-targeted therapeutics exert direct effects on host cells, thus interrupting a "vicious cycle" to bone metastasis that involves osteoblasts, osteoclasts, and tumor cells. Landes Bioscience 2012-11-01 /pmc/articles/PMC3518520/ /pubmed/23243611 http://dx.doi.org/10.4161/onci.21060 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Hurchla, Michelle A.
Weilbaecher, Katherine N.
Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
title Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
title_full Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
title_fullStr Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
title_full_unstemmed Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
title_short Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
title_sort hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518520/
https://www.ncbi.nlm.nih.gov/pubmed/23243611
http://dx.doi.org/10.4161/onci.21060
work_keys_str_mv AT hurchlamichellea hedgehogtargetedtherapeuticsuncoupletheviciouscycleofbonemetastasis
AT weilbaecherkatherinen hedgehogtargetedtherapeuticsuncoupletheviciouscycleofbonemetastasis